Y Moriyama
About
In The Last Decade
Y Moriyama
24 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Gastroenterology 2.7k
- Pulmonary and Respiratory Medicine 2.3k
- Surgery 1.4k
- Hematology 714
- Oncology 517
Countries citing papers authored by Y Moriyama
This map shows the geographic impact of Y Moriyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Moriyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Moriyama more than expected).
Fields of papers citing papers by Y Moriyama
This network shows the impact of papers produced by Y Moriyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Moriyama. The network helps show where Y Moriyama may publish in the future.
Co-authorship network of co-authors of Y Moriyama
This figure shows the co-authorship network connecting the top 25 collaborators of Y Moriyama. A scholar is included among the top collaborators of Y Moriyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Moriyama. Y Moriyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 15 | |
| 3 | 8 | |
| 4 | 107 | |
| 5 | Effect of pirarubicin for elderly patients with malignant lymphoma. | 19 |
| 6 | Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors breakdown → | 3468 |
| 7 | 60 | |
| 8 | 4 | |
| 9 | 78 | |
| 10 | [Allogenic bone marrow transplantation for Fanconi's anemia with leukemic transformation from an HLA identical father]. | 1 |
| 11 | FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. | 46 |
| 12 | Phase II study of FK 506 for allogeneic bone marrow transplantation. | 21 |
| 13 | Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation. | 64 |
| 14 | Administration of human urinary colony stimulating factor after bone marrow transplantation. | 37 |
| 15 | Interstitial pneumonitis in allogeneic bone marrow transplantation: a report from the Japanese BMT Study Group. | 7 |
| 16 | Hemorrhagic cystitis after conditioning for bone marrow transplantation and its prophylaxis. | 8 |
| 17 | [A new Ph1 positive cell line (KU812) from a patient with blastic crisis of chronic myelogenous leukemia]. | 6 |
| 18 | Efficacy of laminar air flow room with or without clean nursing for preventing infection in patients with acute leukemia. | 5 |
| 19 | [A case of acute monoblastic leukemia with ribosome lamella complex-like structure in leukemic cells (author's transl)]. | 1 |
| 20 | Circulating erythropoitic precursors in patients with aplastic anemia and chronic granulocytic leukemia. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.